Home > Analytics > ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS
Intrinsic Value | Fundamental Analysis

BOM : 540788     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : NA
Jul 01,2022
Price(EOD): ₹ 54.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: ₹ 56.19 Cr
Value of ₹ 1 Lac invested in ASPIRA PATHLAB & DIAGNOSTICS
on Feb 28,2018 (price: ₹ 14.15)

₹ 1 L

₹ 3.86 L

1W : -0.9% 1M : -3.1% 1Y : 38.8%
COMMUNITY POLL
for ASPIRA PATHLAB & DIAGNOSTICS
Please provide your vote to see the results
ASPIRA PATHLAB & DIAGNOSTICS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
ASPIRA PATHLAB & DIAGNOSTICS -0.9% -3.1% 38.8%
APOLLO HOSPITALS ENTERPRISE -1.5% 2.5% 2.5%
MAX HEALTHCARE INSTITUTE -3.9% -6.5% 45%
DR LAL PATHLABS 6.2% 4.6% -32.2%
FORTIS HEALTHCARE 2.3% -2.3% -0.2%
METROPOLIS HEALTHCARE -0.3% -8.8% -49.6%
ASTER DM HEALTHCARE -0.8% -10.9% 14.6%
NARAYANA HRUDAYALAYA 1% -1% 31.8%
KRISHNA INSTITUTE OF MEDICAL SCIENCES 5.3% -3.4% NA

FUNDAMENTAL ANALYSIS OF ASPIRA PATHLAB & DIAGNOSTICS

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF ASPIRA PATHLAB & DIAGNOSTICS

 
Valuation Score
[As on : Jul 01,2022 ]

Ratio Standalone
P/E
P/B
P/S
40.71
P/E Calculated based on EPS of 1.34
[ Mar2021 - Standalone Results ]

6.75
P/B Calculated based on Book Value of 8.08
[ Mar2021 - Standalone Results ]

2.88
P/S Calculated based on Revenues of 19.543 Cr
[ TTM - Standalone Results ]

Financial Ratios →

Insights 💡 ASPIRA PATHLAB & DIAGNOSTICS is one of the potential top 22% undervalued companies ! Discover More →

FAIR VALUE OF ASPIRA PATHLAB & DIAGNOSTICS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
-50%
-24%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF ASPIRA PATHLAB & DIAGNOSTICS



ASPIRA PATHLAB & DIAGNOSTICS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF ASPIRA PATHLAB & DIAGNOSTICS

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.15
2.04
1.46
1.22
-
-
-
-
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF ASPIRA PATHLAB & DIAGNOSTICS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF ASPIRA PATHLAB & DIAGNOSTICS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
15.01%
59.77%
66.05%
66.05%
31.98%
112.21%
236.36%
236.36%
QtrlyTrend
8
Latest Qtr: Mar2022
Quarterly Result Analysis →

Insights 💡 ASPIRA PATHLAB & DIAGNOSTICS is one of the top 41% companies with good quarterly result uptrend ! Discover More →

ASPIRA PATHLAB & DIAGNOSTICS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ASPIRA PATHLAB & DIAGNOSTICS


Is ASPIRA PATHLAB & DIAGNOSTICS good for long term investment?

As on Jul 01,2022, the Fundamentals of ASPIRA PATHLAB & DIAGNOSTICS look Poor and hence it may not be good for long term investment ! See Financial Performance of ASPIRA PATHLAB & DIAGNOSTICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ASPIRA PATHLAB & DIAGNOSTICS UnderValued or OverValued?

As on Jul 01,2022, ASPIRA PATHLAB & DIAGNOSTICS is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of ASPIRA PATHLAB & DIAGNOSTICS ?

As on Jul 01,2022, the Intrinsic Value of ASPIRA PATHLAB & DIAGNOSTICS is Rs. 89.96 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -8.83
Fair Value [Median EV / Sales Model] : Rs. 108.37
Fair Value [Median Price / Sales Model] : Rs. 71.54
Median Fair Value of ASPIRA PATHLAB & DIAGNOSTICS : Rs. 89.96

Is ASPIRA PATHLAB & DIAGNOSTICS trading at a Premium or Discount?

As on Jul 01,2022, ASPIRA PATHLAB & DIAGNOSTICS is trading at a Discount of -39% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].